MEGF9: A Drug Target / Disease Biomarker (G1955)

Target Name: MEGF9

NCBI ID: G1955

MEGF9

MEGF9: A Drug Target / Disease Biomarker

MEGF9, short for Mucin Extracellular Factor 9, is a protein that is expressed in various cell types in the body. It is a key regulator of cell signaling pathways, including the TGF-β pathway. TGF-β is a well-known protein that plays a crucial role in the development and maintenance of tissues, including skin, hair, and nails. MEGF9 has also been shown to be involved in the regulation of cell adhesion, migration, and invasion.

In addition to its role in cell signaling pathways, MEGF9 has also been shown to be a potential drug target.MEGF9 has been shown to be involved in the regulation of cell adhesion, which is a critical process that allows cells to stick together and form tissues. This is important for the development and maintenance of tissues, including organs and tissues.

MEGF9 has also been shown to be involved in the regulation of cell migration and invasion. During the development of tissues, cells must move and invade new territories in order to grow and develop. MEGF9 has been shown to play a role in the regulation of cell migration and invasion, which is essential for the formation of tissues during development.

In addition to its role in cell signaling pathways and cell migration and invasion, MEGF9 has also been shown to be involved in the regulation of cell survival. This is important for the regulation of cell division and the maintenance of tissue homeostasis.

Overall, MEGF9 is a protein that has important roles in various cell signaling pathways, including TGF-β, cell adhesion, migration, and invasion. Its potential as a drug target makes it an attractive target for researchers to investigate further. Further studies are needed to fully understand the role of MEGF9 in cell signaling pathways and its potential as a drug target.

Protein Name: Multiple EGF Like Domains 9

The "MEGF9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MEGF9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets